-
effectivehealthcare.ahrq.gov/sites/default/files/considerations-for-statistical-chapter-10.pptx
January 01, 2013 - Covariate Selection for Observational Comparative Effectiveness Research
Considerations for Statistical Analysis in Observational Comparative Effectiveness Research
Prepared for:
Agency for Healthcare Research and Quality (AHRQ)
www.ahrq.gov
Considerations for Statistical Analysis in Observational Comparative Effe…
-
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/patient-participant-generated-registries-guide-3rd-ed-addendum-white-paper.pdf
February 01, 2018 - The drug, called Sarasar by its manufacturer Schering-Plough, was tested in Phase
I/II/III clinical
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-social-isolation-older-adults-final.pdf
February 01, 2019 - studies,34, 36-38 including one fair-quality RCT38 and
three poor-quality pre-post studies,34, 36, 37 tested
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/peripheral-artery-disease-treatment_research-protocol.pdf
January 31, 2013 - discussed in the next section) are
asymptomatic, though they usually have functional impairment when tested … Before they are used, abstraction form templates will be
pilot tested with a sample of included articles
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-quantitative-synthesis-chapter-3.pdf
February 01, 2018 - Quantitative Synthesis Chapter 3. Choice of Statistical Model for Combining Studies
Quantitative Synthesis
Chapter 3. Choice of Statistical Model for Combining Studies
Prepared for:
The Agency for Healthcare Research and Quality (AHRQ)
Training Modules for Systematic Reviews Methods Guide
www.ahrq.gov
Presenter…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia_executive.pdf
May 01, 2006 - Layout 1
Background
Anemia (deficiency of red blood cells)
occurs in 13-78 percent of patients
undergoing treatment for solid tumors and
30-40 percent of patients treated for
lymphoma. Tumor type, treatment
regimen, and history of prior cancer
therapy influence the risk and severity of
anemia. For example, among pa…